120 related articles for article (PubMed ID: 14998983)
1. Effect of subinhibitory concentrations of azithromycin on adherence of Pseudomonas aeruginosa to bronchial mucins collected from cystic fibrosis patients.
Carfartan G; Gerardin P; Turck D; Husson MO
J Antimicrob Chemother; 2004 Apr; 53(4):686-8. PubMed ID: 14998983
[No Abstract] [Full Text] [Related]
2. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa].
Reinert P
Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081
[TBL] [Abstract][Full Text] [Related]
3. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.
Nguyen D; Emond MJ; Mayer-Hamblett N; Saiman L; Marshall BC; Burns JL
Pediatr Pulmonol; 2007 Jun; 42(6):533-41. PubMed ID: 17469154
[TBL] [Abstract][Full Text] [Related]
4. [Bronchial mucins and infection in cystic fibrosis].
Lamblin G; Ramphal R
Pathol Biol (Paris); 1991 Jun; 39(6):592-7. PubMed ID: 1923590
[No Abstract] [Full Text] [Related]
5. Effect of subminimal inhibitory concentrations of azithromycin on adherence of Pseudomonas aeruginosa to polystyrene.
Vranes J
J Chemother; 2000 Aug; 12(4):280-5. PubMed ID: 10949976
[TBL] [Abstract][Full Text] [Related]
6. Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa.
Carnoy C; Ramphal R; Scharfman A; Lo-Guidice JM; Houdret N; Klein A; Galabert C; Lamblin G; Roussel P
Am J Respir Cell Mol Biol; 1993 Sep; 9(3):323-34. PubMed ID: 8398170
[TBL] [Abstract][Full Text] [Related]
7. The effect of subinhibitory concentrations of antibiotics on adherence of Pseudomonas aeruginosa to cystic fibrosis (CF) and non-CF-affected tracheal epithelial cells.
Wolter JM; McCormack JG
J Infect; 1998 Nov; 37(3):217-23. PubMed ID: 9892524
[TBL] [Abstract][Full Text] [Related]
8. Adherence ability of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis to two different epithelial cell lines.
Vranes J; Tjesić-Drinković D; Zulj I; Kruzić V; Turković B; Marić S
Coll Antropol; 2004 Dec; 28(2):675-80. PubMed ID: 15666599
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients.
Traczewski MM; Brown SD
Antimicrob Agents Chemother; 2006 Feb; 50(2):819-21. PubMed ID: 16436756
[TBL] [Abstract][Full Text] [Related]
10. Effects of subminimal inhibitory concentrations of antibiotics on the adherence of Pseudomonas aeruginosa to tracheobronchial mucin.
Vishwanath S; Guay CM; Ramphal R
J Antimicrob Chemother; 1987 May; 19(5):579-83. PubMed ID: 2886486
[TBL] [Abstract][Full Text] [Related]
11. Exploring the mechanisms of macrolides in cystic fibrosis.
Equi AC; Davies JC; Painter H; Hyde S; Bush A; Geddes DM; Alton EW
Respir Med; 2006 Apr; 100(4):687-97. PubMed ID: 16185859
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of a new E-test method for antimicrobial sensitivity testing of Pseudomonas aeruginosa isolates from cystic fibrosis].
Zebouh M; Thomas C; Honderlick P; Lemee L; Segonds C; Wallet F; Husson MO
Pathol Biol (Paris); 2005; 53(8-9):490-4. PubMed ID: 16087300
[TBL] [Abstract][Full Text] [Related]
13. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
Lapointe JR; Bourget C; Mainville S; Lafleur L; Lagacé J; Montplaisir S
J Chemother; 1989 Jul; 1(4 Suppl):184-6. PubMed ID: 16312360
[No Abstract] [Full Text] [Related]
14. Comparative evaluation of the effect of different growth media on in vitro sensitivity to azithromycin in multi-drug resistant Pseudomonas aeruginosa isolated from cystic fibrosis patients.
Sörensen M; Khakimov B; Nurjadi D; Boutin S; Yi B; Dalpke AH; Eigenbrod T
Antimicrob Resist Infect Control; 2020 Dec; 9(1):197. PubMed ID: 33298147
[TBL] [Abstract][Full Text] [Related]
15. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
Hansen CR; Pressler T; Hoiby N; Johansen HK
J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
[TBL] [Abstract][Full Text] [Related]
16. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK
Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
[TBL] [Abstract][Full Text] [Related]
17. Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients.
Wagner T; Soong G; Sokol S; Saiman L; Prince A
Chest; 2005 Aug; 128(2):912-9. PubMed ID: 16100186
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial properties of liposomal azithromycin for Pseudomonas infections in cystic fibrosis patients.
Solleti VS; Alhariri M; Halwani M; Omri A
J Antimicrob Chemother; 2015 Mar; 70(3):784-96. PubMed ID: 25416744
[TBL] [Abstract][Full Text] [Related]
19. Disease surveillance using bronchoalveolar lavage.
Brennan S; Gangell C; Wainwright C; Sly PD
Paediatr Respir Rev; 2008 Sep; 9(3):151-9. PubMed ID: 18694706
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of azithromycin as an antipseudomonal agent.
Mahapatra A; Mahapatra A; Padhi S; Mahapatro S; Ghosh SK
Indian J Pathol Microbiol; 2006 Oct; 49(4):634-5. PubMed ID: 17183885
[No Abstract] [Full Text] [Related]
[Next] [New Search]
